206 related articles for article (PubMed ID: 25763208)
1. Intravitreal clindamycin in the treatment of unresponsive zone one toxoplasmic chorioretinitis: a case report.
Hosseini SM; Abrishami M; Mehdi Zadeh M
Iran Red Crescent Med J; 2014 Nov; 16(11):e15428. PubMed ID: 25763208
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal clindamycin plus dexamethasone versus classic oral therapy in toxoplasmic retinochoroiditis: a prospective randomized clinical trial.
Baharivand N; Mahdavifard A; Fouladi RF
Int Ophthalmol; 2013 Feb; 33(1):39-46. PubMed ID: 23053769
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series.
Verma L; Thulasidas M; Gupta A
Clin Ophthalmol; 2020; 14():4279-4285. PubMed ID: 33324033
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis.
Kishore K; Conway MD; Peyman GA
Ophthalmic Surg Lasers; 2001; 32(3):183-92. PubMed ID: 11371084
[TBL] [Abstract][Full Text] [Related]
5. Local treatment of toxoplasmic retinochoroiditis with intravitreal clindamycin and dexamethasone.
Zamora YF; Arantes T; Reis FA; Garcia CR; Saraceno JJ; Belfort R; Muccioli C
Arq Bras Oftalmol; 2015; 78(4):216-9. PubMed ID: 26375334
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal clindamycin for toxoplasmic retinochoroiditis.
Sobrin L; Kump LI; Foster CS
Retina; 2007 Sep; 27(7):952-7. PubMed ID: 17891023
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal clindamycin and dexamethasone for zone 1 toxoplasmic retinochoroiditis at twenty-four months.
Lasave AF; Díaz-Llopis M; Muccioli C; Belfort R; Arevalo JF
Ophthalmology; 2010 Sep; 117(9):1831-8. PubMed ID: 20471684
[TBL] [Abstract][Full Text] [Related]
8. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
[TBL] [Abstract][Full Text] [Related]
9. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
Colin J; Harie JC
J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
[TBL] [Abstract][Full Text] [Related]
10. [Intravitreal clindamycin injection in toxoplasma retinochoroiditis: About 9 cases in the ophthalmology department of the CHU de Bordeaux].
Handaye-Dessus A; Gattoussi S; Korobelnik JF; Delyfer MN; Rougier MB
J Fr Ophtalmol; 2021 Sep; 44(7):968-976. PubMed ID: 34247873
[TBL] [Abstract][Full Text] [Related]
11. Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis.
Jorge R; Coelho IN; Silva-Cunha A; Fernandes Cunha GM; Scott IU; Fialho SL; Furtado JM
Am J Ophthalmol Case Rep; 2021 Jun; 22():101093. PubMed ID: 33981913
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
[TBL] [Abstract][Full Text] [Related]
13. Clindamycin in the treatment of toxoplasmic retinochoroiditis.
Lakhanpal V; Schocket SS; Nirankari VS
Am J Ophthalmol; 1983 May; 95(5):605-13. PubMed ID: 6846454
[TBL] [Abstract][Full Text] [Related]
14. [Recurrent toxoplasmic retinochoroiditis after clindamycin treatment].
Benzina Z; Chaabouni S; Hentati N; Trigui A; Chaabouni F; Ben Salah S; Khlif H; Feki J
J Fr Ophtalmol; 2005 Nov; 28(9):958-64. PubMed ID: 16395222
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii: an atypical presentation of toxoplasma as optic disc swelling and hemispherical retinal vein occlusion treated with intravitreal clindamycin.
Wong R; dell'Omo R; Marino M; Hussein B; Okhravi N; Pavesio CE
Int Ophthalmol; 2009 Jun; 29(3):195-8. PubMed ID: 18297246
[TBL] [Abstract][Full Text] [Related]
16. Foveal reorganization after treatment of acute foveal toxoplasmic retinochoroiditis.
Abrishami M; Hosseini SM; Momtahen S; Zamani G
J Ophthalmic Inflamm Infect; 2021 Jun; 11(1):18. PubMed ID: 34151385
[TBL] [Abstract][Full Text] [Related]
17. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis.
Soheilian M; Ramezani A; Azimzadeh A; Sadoughi MM; Dehghan MH; Shahghadami R; Yaseri M; Peyman GA
Ophthalmology; 2011 Jan; 118(1):134-41. PubMed ID: 20708269
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal clindamycin as a therapeutic alternative in severe ocular toxoplasmosis.
Tabuenca Del Barrio L; Heras Mulero H; Mozo Cuadrado M; Fanlo Mateo P; Compains Silva E
Arch Soc Esp Oftalmol (Engl Ed); 2019 Dec; 94(12):602-604. PubMed ID: 31607401
[TBL] [Abstract][Full Text] [Related]
20. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
Zhang Y; Lin X; Lu F
Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]